Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Diabetic Macular Edema
NCT00711490Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Jul 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in diabetic macular edema (DME), sponsored by National Eye Institute. Primary endpoint: Change in Visual Acuity From Baseline to 6 Months. Started Jul 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00711490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711490.